Salvia miltiorrhiza extract
description1
description2
Core Active Components
1. Major Bioactive Compounds
|
Component Category |
Representative Compounds |
Content Range |
Primary Effects |
|
Tanshinones |
Tanshinone IIA |
0.3-0.8% |
Cardiovascular protection (antiplatelet) |
|
Phenolic Acids |
Salvianolic acid B |
3-8% |
Antioxidant (free radical scavenging) |
|
Polysaccharides |
Acidic heteropolysaccharide (SMWP) |
5-12% |
Immunomodulation (lymphocyte proliferation) |
|
Essential Oils |
β-Eudesmol |
0.1-0.5% |
Neuroprotection (microglia inhibition) |
|
Amino Acids |
Arginine |
1-3% |
Microcirculation improvement (NO production) |
2. Synergistic Effects:
● Tanshinone IIA + Salvianolic acid B: Myocardial ischemia protection ↑50%
● Polysaccharides + Zinc: Wound healing speed ↑30%

High Purity

100% Natural

Compliant with standards

Stable supplying

Quality ensured

Versatile Applications
Application Fields Green max
1. Pharmaceutical Uses:
● Cardiology: Coronary heart disease, angina (Danshen Dripping Pills)
● Neurology: Alzheimer's disease adjuvant therapy
2. Functional Foods:
● Cardioprotective capsules: Improves myocardial blood supply
● Antioxidant beverages: ORAC value ≥5000 μmol TE/g
3. Cosmetics:
● Anti-redness serums: Reduces capillary fragility
● Anti-aging creams: Inhibits MMP-1 expression
Future R&D Directions
1. Technological Innovations:
● Nano-liposome encapsulation (5× tanshinone bioavailability)
● Synthetic biology production (yeast-expressed salvianolic acid B)
2. Emerging Applications:
● COVID-19 adjuvant therapy (inhibits cytokine storm)
● Sports medicine: Alleviates muscle ischemia-reperfusion injury
Safety Profile
1. Toxicology Data:
● Acute toxicity: LD50 >15g/kg (practically non-toxic)
● Chronic toxicity: No organ damage in 6-month rat studies
2. Contraindications:
● Caution in bleeding disorders
● Requires INR monitoring with warfarin co-administration
Usage Guidelines
1. Recommended Dosage
|
Application |
Formulation |
Concentration |
Duration |
|
Cardiovascular care |
Oral tablets |
200-400mg/day |
3-6 months |
|
Skin repair |
Topical gel |
1-3% |
4-8 weeks |
|
Neuroprotection |
IV injection |
10-20mg/kg |
2-4 weeks |
2. Precautions:
● Injections may cause transient facial flushing
● Avoid high-dose combinations with anticoagulants
Please Send me email and you can get more what you want.
Such as product of Price, Specification, MOA, MSDS, Flow Chart, Packing details, Shipping Term, Payment Term, after Sale service and so on.
Our experts will solve them in no time.







